MEDVi holds the lowest aggregated rating of any GLP-1 telehealth provider in ConsumersVerified’s current coverage: 1.59 stars from third-party review platforms. That number reflects a documented pattern of billing complaints, customer service issues, and cancellation friction across multiple independent review sources — not a single bad month.
Luma Health is the opposite profile: transparent pharmacy infrastructure, flat-rate pricing significantly below MEDVi’s rates, named clinical provider, and a minimal documented complaint pattern. This comparison is direct.
At a Glance
MEDVi’s 1.59-Star Rating: What It Reflects
A 1.59-star aggregated rating isn’t a coincidence or a competitor review campaign. It reflects a consistent pattern across multiple independent third-party platforms — Google, Trustpilot, the BBB — where real customers describe the same categories of problems repeatedly: billing charges that are difficult to dispute, customer service that is unresponsive, and cancellation processes that generate unexpected additional charges.
These are the three complaint categories that carry the highest predictive weight for future patient experience. When they appear consistently across independent platforms, they describe the company’s operational pattern, not an isolated incident.
MEDVi holds the lowest rating of any provider in our GLP-1 telehealth coverage as of June 2026. See the full MEDVi review profile for the complete complaint and rating data.
Pricing Comparison
MEDVi’s pricing runs higher than Luma Health’s across both primary medications, making it simultaneously the most expensive and the worst-rated provider in our GLP-1 coverage. On semaglutide, the $90/month vs. $249/month difference represents $1,908/year. On tirzepatide at $165/month vs. $349/month, the annual difference is $2,208.
There is no consumer case for MEDVi over Luma Health. It costs more, has a significantly worse documented complaint history, does not publicly name its pharmacy, and does not offer the flat-rate billing structure that eliminates dose-tier surprise increases.
Verdict
This is the most direct comparison in our Luma Health series. Luma Health is lower-priced, more transparently documented, has significantly stronger pharmacy disclosure, and has a negligible complaint pattern versus MEDVi’s documented 1.59-star history. There is no scenario in which MEDVi is the better choice for a patient who has evaluated both providers on their merits.
Start With Luma Health
Compounded semaglutide $90/mo • Tirzepatide $165/mo • Named pharmacy • No complaint pattern
FAQ
Is MEDVi a scam?
MEDVi is a real operating telehealth company, not a fraudulent operation. However, its 1.59-star rating reflects genuine, documented patient dissatisfaction across multiple independent platforms. The complaint patterns — billing, cancellation, customer service — are consistent enough that ConsumersVerified does not recommend MEDVi as a GLP-1 provider and recommends patients evaluate alternatives like Luma Health before enrolling.
Has MEDVi improved recently?
We update our ratings on an ongoing basis from third-party platform data. As of June 2026, MEDVi’s aggregated rating remains at the level reflected in this article. If you are considering MEDVi, check the most recent reviews on Trustpilot and the BBB before making your decision.
⚖️ Compare All GLP-1 Weight Loss Programs
Read verified reviews for every major weight loss telehealth provider on ConsumersVerified.